More and more clinical trials are going site-less – recent market analysis estimates a compounded annual growth rate for site-less trials up to 14.75% in the coming years. Have you considered how this rapid increase will affect your organization?
Elligo offers you an innovative alternative to site-less trials, protecting your bottom line and keeping patients at your site. Elligo’s model offers you additional valuable “only through Elligo” trial opportunities and puts you and your patients first by using ResearchConnect®, our HIPAA-compliant identified healthcare data access platform, to identify patients for trials before they start. Once identified, you directly enroll patients into trials — keeping both trials and revenue at your site.
Elligo is exclusively offering valued ClinEdge clients free ResearchConnect® installations for 90 days. Don’t lose business to site-less trials. Boost your revenue while giving your patients greater access to research as care with Elligo.
Sign up today to claim your FREE, no-risk, no-obligation ResearchConnect® 90-day trial.